nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—CYP3A4—type 2 diabetes mellitus	0.4	1	CbGaD
Alimemazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0647	0.152	CbGbCtD
Alimemazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0577	0.136	CbGbCtD
Alimemazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0528	0.124	CbGbCtD
Alimemazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0461	0.109	CbGbCtD
Alimemazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0417	0.0982	CbGbCtD
Alimemazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0316	0.0744	CbGbCtD
Alimemazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0303	0.0713	CbGbCtD
Alimemazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0303	0.0713	CbGbCtD
Alimemazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0287	0.0675	CbGbCtD
Alimemazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0213	0.0503	CbGbCtD
Alimemazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0195	0.046	CbGbCtD
Alimemazine—Hyperprolactinaemia—Bromocriptine—type 2 diabetes mellitus	0.00507	0.0339	CcSEcCtD
Alimemazine—Jaundice cholestatic—Tolbutamide—type 2 diabetes mellitus	0.00324	0.0217	CcSEcCtD
Alimemazine—Parkinsonism—Bromocriptine—type 2 diabetes mellitus	0.00319	0.0213	CcSEcCtD
Alimemazine—Jaundice cholestatic—Chlorpropamide—type 2 diabetes mellitus	0.00295	0.0197	CcSEcCtD
Alimemazine—Jaundice cholestatic—Tolazamide—type 2 diabetes mellitus	0.00295	0.0197	CcSEcCtD
Alimemazine—Neuroleptic malignant syndrome—Bromocriptine—type 2 diabetes mellitus	0.00283	0.0189	CcSEcCtD
Alimemazine—Arrhythmia supraventricular—Irbesartan—type 2 diabetes mellitus	0.00242	0.0162	CcSEcCtD
Alimemazine—Jaundice cholestatic—Glipizide—type 2 diabetes mellitus	0.00196	0.0131	CcSEcCtD
Alimemazine—Excitement—Irbesartan—type 2 diabetes mellitus	0.00191	0.0128	CcSEcCtD
Alimemazine—Pallor—Bromocriptine—type 2 diabetes mellitus	0.00175	0.0117	CcSEcCtD
Alimemazine—Photosensitivity reaction—Tolbutamide—type 2 diabetes mellitus	0.00163	0.0109	CcSEcCtD
Alimemazine—Eosinophilia—Chlorpropamide—type 2 diabetes mellitus	0.00161	0.0108	CcSEcCtD
Alimemazine—Dyskinesia—Bromocriptine—type 2 diabetes mellitus	0.00154	0.0103	CcSEcCtD
Alimemazine—Jaundice cholestatic—Glyburide—type 2 diabetes mellitus	0.00151	0.0101	CcSEcCtD
Alimemazine—Agranulocytosis—Tolbutamide—type 2 diabetes mellitus	0.00149	0.00995	CcSEcCtD
Alimemazine—Photosensitivity reaction—Chlorpropamide—type 2 diabetes mellitus	0.00148	0.00993	CcSEcCtD
Alimemazine—Photosensitivity reaction—Tolazamide—type 2 diabetes mellitus	0.00148	0.00993	CcSEcCtD
Alimemazine—Ventricular tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00145	0.00969	CcSEcCtD
Alimemazine—Pallor—Gliclazide—type 2 diabetes mellitus	0.00143	0.00959	CcSEcCtD
Alimemazine—Jaundice—Acarbose—type 2 diabetes mellitus	0.00136	0.00909	CcSEcCtD
Alimemazine—Agranulocytosis—Chlorpropamide—type 2 diabetes mellitus	0.00135	0.00905	CcSEcCtD
Alimemazine—Agranulocytosis—Tolazamide—type 2 diabetes mellitus	0.00135	0.00905	CcSEcCtD
Alimemazine—Jaundice cholestatic—Gliclazide—type 2 diabetes mellitus	0.00135	0.00905	CcSEcCtD
Alimemazine—Jaundice—Nateglinide—type 2 diabetes mellitus	0.00131	0.00876	CcSEcCtD
Alimemazine—Amenorrhoea—Orlistat—type 2 diabetes mellitus	0.00123	0.00822	CcSEcCtD
Alimemazine—Nasal congestion—Bromocriptine—type 2 diabetes mellitus	0.00115	0.00772	CcSEcCtD
Alimemazine—Jaundice—Repaglinide—type 2 diabetes mellitus	0.00113	0.00758	CcSEcCtD
Alimemazine—Jaundice cholestatic—Irbesartan—type 2 diabetes mellitus	0.00107	0.00715	CcSEcCtD
Alimemazine—Orthostatic hypotension—Sitagliptin—type 2 diabetes mellitus	0.00106	0.0071	CcSEcCtD
Alimemazine—Jaundice cholestatic—Losartan—type 2 diabetes mellitus	0.00101	0.00672	CcSEcCtD
Alimemazine—Eosinophilia—Glimepiride—type 2 diabetes mellitus	0.000997	0.00667	CcSEcCtD
Alimemazine—Photosensitivity reaction—Glipizide—type 2 diabetes mellitus	0.000985	0.00659	CcSEcCtD
Alimemazine—Tremor—Nateglinide—type 2 diabetes mellitus	0.000984	0.00658	CcSEcCtD
Alimemazine—Photosensitivity—Gliclazide—type 2 diabetes mellitus	0.000982	0.00657	CcSEcCtD
Alimemazine—Cardiac disorder—Repaglinide—type 2 diabetes mellitus	0.000969	0.00648	CcSEcCtD
Alimemazine—Orthostatic hypotension—Bromocriptine—type 2 diabetes mellitus	0.00096	0.00642	CcSEcCtD
Alimemazine—Erectile dysfunction—Pioglitazone—type 2 diabetes mellitus	0.000952	0.00637	CcSEcCtD
Alimemazine—Jaundice—Glipizide—type 2 diabetes mellitus	0.000938	0.00627	CcSEcCtD
Alimemazine—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.000932	0.00624	CcSEcCtD
Alimemazine—Erectile dysfunction—Sitagliptin—type 2 diabetes mellitus	0.000924	0.00619	CcSEcCtD
Alimemazine—Photosensitivity reaction—Glimepiride—type 2 diabetes mellitus	0.000919	0.00615	CcSEcCtD
Alimemazine—Cardiac disorder—Rosiglitazone—type 2 diabetes mellitus	0.000916	0.00613	CcSEcCtD
Alimemazine—Infection—Linagliptin—type 2 diabetes mellitus	0.000909	0.00608	CcSEcCtD
Alimemazine—Photosensitivity—Valsartan—type 2 diabetes mellitus	0.000903	0.00604	CcSEcCtD
Alimemazine—Agranulocytosis—Glipizide—type 2 diabetes mellitus	0.000898	0.00601	CcSEcCtD
Alimemazine—Ventricular tachycardia—Losartan—type 2 diabetes mellitus	0.000883	0.00591	CcSEcCtD
Alimemazine—Jaundice—Glimepiride—type 2 diabetes mellitus	0.000875	0.00586	CcSEcCtD
Alimemazine—Jaundice cholestatic—Ramipril—type 2 diabetes mellitus	0.000862	0.00577	CcSEcCtD
Alimemazine—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	0.000838	0.00561	CcSEcCtD
Alimemazine—Eosinophilia—Glyburide—type 2 diabetes mellitus	0.000822	0.0055	CcSEcCtD
Alimemazine—Nasal congestion—Metformin—type 2 diabetes mellitus	0.000792	0.0053	CcSEcCtD
Alimemazine—Photosensitivity—Irbesartan—type 2 diabetes mellitus	0.000776	0.00519	CcSEcCtD
Alimemazine—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.000772	0.00516	CcSEcCtD
Alimemazine—Cardiac disorder—Pioglitazone—type 2 diabetes mellitus	0.000768	0.00514	CcSEcCtD
Alimemazine—Photosensitivity reaction—Glyburide—type 2 diabetes mellitus	0.000758	0.00507	CcSEcCtD
Alimemazine—Cardiac disorder—Sitagliptin—type 2 diabetes mellitus	0.000746	0.00499	CcSEcCtD
Alimemazine—Photosensitivity—Losartan—type 2 diabetes mellitus	0.00073	0.00488	CcSEcCtD
Alimemazine—Orthostatic hypotension—Valsartan—type 2 diabetes mellitus	0.000724	0.00484	CcSEcCtD
Alimemazine—Jaundice—Glyburide—type 2 diabetes mellitus	0.000722	0.00483	CcSEcCtD
Alimemazine—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.00072	0.00482	CcSEcCtD
Alimemazine—Rash—Miglitol—type 2 diabetes mellitus	0.000713	0.00477	CcSEcCtD
Alimemazine—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.000713	0.00477	CcSEcCtD
Alimemazine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000712	0.00477	CcSEcCtD
Alimemazine—Tremor—Glipizide—type 2 diabetes mellitus	0.000704	0.00471	CcSEcCtD
Alimemazine—Nasal congestion—Losartan—type 2 diabetes mellitus	0.000704	0.00471	CcSEcCtD
Alimemazine—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000696	0.00466	CcSEcCtD
Alimemazine—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.000691	0.00462	CcSEcCtD
Alimemazine—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000687	0.0046	CcSEcCtD
Alimemazine—Erectile dysfunction—Gliclazide—type 2 diabetes mellitus	0.000687	0.00459	CcSEcCtD
Alimemazine—Photosensitivity reaction—Gliclazide—type 2 diabetes mellitus	0.000681	0.00455	CcSEcCtD
Alimemazine—Gynaecomastia—Ramipril—type 2 diabetes mellitus	0.000677	0.00453	CcSEcCtD
Alimemazine—Cardiac disorder—Bromocriptine—type 2 diabetes mellitus	0.000675	0.00451	CcSEcCtD
Alimemazine—Tremor—Glimepiride—type 2 diabetes mellitus	0.000657	0.0044	CcSEcCtD
Alimemazine—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.00065	0.00435	CcSEcCtD
Alimemazine—Jaundice—Gliclazide—type 2 diabetes mellitus	0.000648	0.00434	CcSEcCtD
Alimemazine—Agitation—Glimepiride—type 2 diabetes mellitus	0.000645	0.00431	CcSEcCtD
Alimemazine—Rash—Tolbutamide—type 2 diabetes mellitus	0.000641	0.00429	CcSEcCtD
Alimemazine—Erectile dysfunction—Valsartan—type 2 diabetes mellitus	0.000631	0.00422	CcSEcCtD
Alimemazine—Photosensitivity—Ramipril—type 2 diabetes mellitus	0.000626	0.00419	CcSEcCtD
Alimemazine—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000625	0.00418	CcSEcCtD
Alimemazine—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000622	0.00416	CcSEcCtD
Alimemazine—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.00062	0.00415	CcSEcCtD
Alimemazine—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.00062	0.00415	CcSEcCtD
Alimemazine—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000608	0.00407	CcSEcCtD
Alimemazine—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.000603	0.00404	CcSEcCtD
Alimemazine—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000585	0.00392	CcSEcCtD
Alimemazine—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000584	0.00391	CcSEcCtD
Alimemazine—Infection—Pioglitazone—type 2 diabetes mellitus	0.000584	0.00391	CcSEcCtD
Alimemazine—Rash—Tolazamide—type 2 diabetes mellitus	0.000583	0.0039	CcSEcCtD
Alimemazine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000583	0.0039	CcSEcCtD
Alimemazine—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000582	0.0039	CcSEcCtD
Alimemazine—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000582	0.00389	CcSEcCtD
Alimemazine—Rash—Linagliptin—type 2 diabetes mellitus	0.000577	0.00386	CcSEcCtD
Alimemazine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000577	0.00386	CcSEcCtD
Alimemazine—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000576	0.00386	CcSEcCtD
Alimemazine—Infection—Sitagliptin—type 2 diabetes mellitus	0.000567	0.00379	CcSEcCtD
Alimemazine—Rash—Acarbose—type 2 diabetes mellitus	0.00056	0.00375	CcSEcCtD
Alimemazine—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00056	0.00375	CcSEcCtD
Alimemazine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00056	0.00375	CcSEcCtD
Alimemazine—Insomnia—Glipizide—type 2 diabetes mellitus	0.000555	0.00371	CcSEcCtD
Alimemazine—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000549	0.00367	CcSEcCtD
Alimemazine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000548	0.00367	CcSEcCtD
Alimemazine—Tremor—Glyburide—type 2 diabetes mellitus	0.000542	0.00363	CcSEcCtD
Alimemazine—Rash—Nateglinide—type 2 diabetes mellitus	0.00054	0.00361	CcSEcCtD
Alimemazine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00054	0.00361	CcSEcCtD
Alimemazine—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000537	0.0036	CcSEcCtD
Alimemazine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000535	0.00358	CcSEcCtD
Alimemazine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000533	0.00357	CcSEcCtD
Alimemazine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000532	0.00356	CcSEcCtD
Alimemazine—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000527	0.00353	CcSEcCtD
Alimemazine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000518	0.00347	CcSEcCtD
Alimemazine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000516	0.00345	CcSEcCtD
Alimemazine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000513	0.00343	CcSEcCtD
Alimemazine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000512	0.00342	CcSEcCtD
Alimemazine—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.00051	0.00341	CcSEcCtD
Alimemazine—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000509	0.0034	CcSEcCtD
Alimemazine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000507	0.00339	CcSEcCtD
Alimemazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000506	0.00338	CcSEcCtD
Alimemazine—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000502	0.00336	CcSEcCtD
Alimemazine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000501	0.00335	CcSEcCtD
Alimemazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.00049	0.00328	CcSEcCtD
Alimemazine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000487	0.00326	CcSEcCtD
Alimemazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000483	0.00323	CcSEcCtD
Alimemazine—Jaundice—Losartan—type 2 diabetes mellitus	0.000482	0.00322	CcSEcCtD
Alimemazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000477	0.00319	CcSEcCtD
Alimemazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.00047	0.00315	CcSEcCtD
Alimemazine—Rash—Repaglinide—type 2 diabetes mellitus	0.000468	0.00313	CcSEcCtD
Alimemazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000467	0.00313	CcSEcCtD
Alimemazine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000467	0.00313	CcSEcCtD
Alimemazine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000463	0.0031	CcSEcCtD
Alimemazine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000463	0.0031	CcSEcCtD
Alimemazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000461	0.00308	CcSEcCtD
Alimemazine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00045	0.00301	CcSEcCtD
Alimemazine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000442	0.00296	CcSEcCtD
Alimemazine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000442	0.00295	CcSEcCtD
Alimemazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000441	0.00295	CcSEcCtD
Alimemazine—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000438	0.00293	CcSEcCtD
Alimemazine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000437	0.00293	CcSEcCtD
Alimemazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000434	0.0029	CcSEcCtD
Alimemazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000433	0.00289	CcSEcCtD
Alimemazine—Infection—Gliclazide—type 2 diabetes mellitus	0.000421	0.00282	CcSEcCtD
Alimemazine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000421	0.00282	CcSEcCtD
Alimemazine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000416	0.00278	CcSEcCtD
Alimemazine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000413	0.00276	CcSEcCtD
Alimemazine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000409	0.00273	CcSEcCtD
Alimemazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000408	0.00273	CcSEcCtD
Alimemazine—Tremor—Metformin—type 2 diabetes mellitus	0.000407	0.00272	CcSEcCtD
Alimemazine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000397	0.00266	CcSEcCtD
Alimemazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000396	0.00265	CcSEcCtD
Alimemazine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000396	0.00265	CcSEcCtD
Alimemazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000395	0.00264	CcSEcCtD
Alimemazine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000393	0.00263	CcSEcCtD
Alimemazine—Infection—Valsartan—type 2 diabetes mellitus	0.000387	0.00259	CcSEcCtD
Alimemazine—Rash—Glipizide—type 2 diabetes mellitus	0.000387	0.00259	CcSEcCtD
Alimemazine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000387	0.00259	CcSEcCtD
Alimemazine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000384	0.00257	CcSEcCtD
Alimemazine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000384	0.00257	CcSEcCtD
Alimemazine—Infection—Orlistat—type 2 diabetes mellitus	0.000382	0.00256	CcSEcCtD
Alimemazine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000382	0.00256	CcSEcCtD
Alimemazine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000378	0.00253	CcSEcCtD
Alimemazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000377	0.00252	CcSEcCtD
Alimemazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000364	0.00244	CcSEcCtD
Alimemazine—Tremor—Losartan—type 2 diabetes mellitus	0.000362	0.00242	CcSEcCtD
Alimemazine—Rash—Glimepiride—type 2 diabetes mellitus	0.000361	0.00242	CcSEcCtD
Alimemazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000361	0.00241	CcSEcCtD
Alimemazine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00036	0.00241	CcSEcCtD
Alimemazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00036	0.00241	CcSEcCtD
Alimemazine—Agitation—Losartan—type 2 diabetes mellitus	0.000355	0.00237	CcSEcCtD
Alimemazine—Infection—Metformin—type 2 diabetes mellitus	0.000352	0.00236	CcSEcCtD
Alimemazine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000352	0.00236	CcSEcCtD
Alimemazine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000348	0.00233	CcSEcCtD
Alimemazine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000348	0.00233	CcSEcCtD
Alimemazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000342	0.00229	CcSEcCtD
Alimemazine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00034	0.00227	CcSEcCtD
Alimemazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000335	0.00224	CcSEcCtD
Alimemazine—Infection—Irbesartan—type 2 diabetes mellitus	0.000333	0.00223	CcSEcCtD
Alimemazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000331	0.00222	CcSEcCtD
Alimemazine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000328	0.0022	CcSEcCtD
Alimemazine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000326	0.00218	CcSEcCtD
Alimemazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000325	0.00218	CcSEcCtD
Alimemazine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000321	0.00215	CcSEcCtD
Alimemazine—Infection—Losartan—type 2 diabetes mellitus	0.000313	0.00209	CcSEcCtD
Alimemazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000313	0.00209	CcSEcCtD
Alimemazine—Tremor—Ramipril—type 2 diabetes mellitus	0.00031	0.00208	CcSEcCtD
Alimemazine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000309	0.00207	CcSEcCtD
Alimemazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000304	0.00204	CcSEcCtD
Alimemazine—Agitation—Ramipril—type 2 diabetes mellitus	0.000304	0.00204	CcSEcCtD
Alimemazine—Rash—Glyburide—type 2 diabetes mellitus	0.000298	0.00199	CcSEcCtD
Alimemazine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000297	0.00199	CcSEcCtD
Alimemazine—Hypotension—Losartan—type 2 diabetes mellitus	0.000294	0.00197	CcSEcCtD
Alimemazine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000287	0.00192	CcSEcCtD
Alimemazine—Insomnia—Losartan—type 2 diabetes mellitus	0.000285	0.00191	CcSEcCtD
Alimemazine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000276	0.00184	CcSEcCtD
Alimemazine—Rash—Gliclazide—type 2 diabetes mellitus	0.000267	0.00179	CcSEcCtD
Alimemazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000267	0.00179	CcSEcCtD
Alimemazine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000265	0.00177	CcSEcCtD
Alimemazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000265	0.00177	CcSEcCtD
Alimemazine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000252	0.00169	CcSEcCtD
Alimemazine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000249	0.00167	CcSEcCtD
Alimemazine—Rash—Valsartan—type 2 diabetes mellitus	0.000246	0.00164	CcSEcCtD
Alimemazine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000245	0.00164	CcSEcCtD
Alimemazine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000244	0.00163	CcSEcCtD
Alimemazine—Rash—Orlistat—type 2 diabetes mellitus	0.000243	0.00162	CcSEcCtD
Alimemazine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000242	0.00162	CcSEcCtD
Alimemazine—Rash—Metformin—type 2 diabetes mellitus	0.000224	0.0015	CcSEcCtD
Alimemazine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000223	0.0015	CcSEcCtD
Alimemazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000218	0.0318	CrCbGaD
Alimemazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000214	0.00143	CcSEcCtD
Alimemazine—Rash—Irbesartan—type 2 diabetes mellitus	0.000211	0.00141	CcSEcCtD
Alimemazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000211	0.00141	CcSEcCtD
Alimemazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000208	0.0304	CrCbGaD
Alimemazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.000206	0.03	CrCbGaD
Alimemazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000203	0.0297	CrCbGaD
Alimemazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000201	0.0293	CrCbGaD
Alimemazine—Rash—Losartan—type 2 diabetes mellitus	0.000199	0.00133	CcSEcCtD
Alimemazine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000198	0.00133	CcSEcCtD
Alimemazine—Metixene—HTR2C—type 2 diabetes mellitus	0.000187	0.0272	CrCbGaD
Alimemazine—Rash—Ramipril—type 2 diabetes mellitus	0.00017	0.00114	CcSEcCtD
Alimemazine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00017	0.00114	CcSEcCtD
Alimemazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.000161	0.0235	CrCbGaD
Alimemazine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.000141	0.0205	CrCbGaD
Alimemazine—Carbamazepine—ABCC2—type 2 diabetes mellitus	0.000131	0.0192	CrCbGaD
Alimemazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	0.000122	0.0179	CrCbGaD
Alimemazine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.00012	0.0175	CrCbGaD
Alimemazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000118	0.0173	CrCbGaD
Alimemazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	0.000106	0.0155	CrCbGaD
Alimemazine—Propiomazine—HTR2C—type 2 diabetes mellitus	0.000103	0.015	CrCbGaD
Alimemazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	0.0001	0.0146	CrCbGaD
Alimemazine—Clomipramine—HTR2C—type 2 diabetes mellitus	9.8e-05	0.0143	CrCbGaD
Alimemazine—Trimipramine—ADRA2A—type 2 diabetes mellitus	9.8e-05	0.0143	CrCbGaD
Alimemazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	9.76e-05	0.0142	CrCbGaD
Alimemazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	9.57e-05	0.014	CrCbGaD
Alimemazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	9.36e-05	0.0137	CrCbGaD
Alimemazine—Doxepin—ADRA2A—type 2 diabetes mellitus	9.33e-05	0.0136	CrCbGaD
Alimemazine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	9.32e-05	0.0136	CrCbGaD
Alimemazine—Thioridazine—HTR2C—type 2 diabetes mellitus	9.23e-05	0.0135	CrCbGaD
Alimemazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	9.2e-05	0.0134	CrCbGaD
Alimemazine—Trimipramine—HTR2C—type 2 diabetes mellitus	9.02e-05	0.0132	CrCbGaD
Alimemazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	8.81e-05	0.0129	CrCbGaD
Alimemazine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	8.78e-05	0.0128	CrCbGaD
Alimemazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	8.71e-05	0.0127	CrCbGaD
Alimemazine—Doxepin—HTR2C—type 2 diabetes mellitus	8.59e-05	0.0125	CrCbGaD
Alimemazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	8.57e-05	0.0125	CrCbGaD
Alimemazine—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	8.52e-05	0.0124	CrCbGaD
Alimemazine—Perphenazine—HTR2C—type 2 diabetes mellitus	8.47e-05	0.0124	CrCbGaD
Alimemazine—Promazine—ADRA2A—type 2 diabetes mellitus	8.3e-05	0.0121	CrCbGaD
Alimemazine—Desipramine—HTR2C—type 2 diabetes mellitus	7.89e-05	0.0115	CrCbGaD
Alimemazine—Diltiazem—CYP3A4—type 2 diabetes mellitus	7.81e-05	0.0114	CrCbGaD
Alimemazine—Promazine—HTR2C—type 2 diabetes mellitus	7.64e-05	0.0111	CrCbGaD
Alimemazine—Oxcarbazepine—ALB—type 2 diabetes mellitus	7.44e-05	0.0108	CrCbGaD
Alimemazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	7.4e-05	0.0108	CrCbGaD
Alimemazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	7.32e-05	0.0107	CrCbGaD
Alimemazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	7.3e-05	0.0107	CrCbGaD
Alimemazine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	7.22e-05	0.0105	CrCbGaD
Alimemazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	6.99e-05	0.0102	CrCbGaD
Alimemazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	6.97e-05	0.0102	CrCbGaD
Alimemazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	6.72e-05	0.00981	CrCbGaD
Alimemazine—Imipramine—HTR2C—type 2 diabetes mellitus	6.69e-05	0.00976	CrCbGaD
Alimemazine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	6.68e-05	0.00975	CrCbGaD
Alimemazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	6.65e-05	0.0097	CrCbGaD
Alimemazine—Amitriptyline—HTR2C—type 2 diabetes mellitus	6.65e-05	0.0097	CrCbGaD
Alimemazine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	6.64e-05	0.00969	CrCbGaD
Alimemazine—Doxepin—CYP1A2—type 2 diabetes mellitus	6.48e-05	0.00946	CrCbGaD
Alimemazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	6.46e-05	0.00943	CrCbGaD
Alimemazine—Methadone—CYP1A2—type 2 diabetes mellitus	6.45e-05	0.00941	CrCbGaD
Alimemazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	6.39e-05	0.00933	CrCbGaD
Alimemazine—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	6.3e-05	0.00919	CrCbGaD
Alimemazine—Desipramine—CYP2E1—type 2 diabetes mellitus	6.25e-05	0.00913	CrCbGaD
Alimemazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	6.19e-05	0.00904	CrCbGaD
Alimemazine—Desipramine—CYP1A2—type 2 diabetes mellitus	5.95e-05	0.00868	CrCbGaD
Alimemazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	5.92e-05	0.00864	CrCbGaD
Alimemazine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	5.81e-05	0.00848	CrCbGaD
Alimemazine—Promazine—CYP1A2—type 2 diabetes mellitus	5.76e-05	0.00841	CrCbGaD
Alimemazine—Acepromazine—ALB—type 2 diabetes mellitus	5.62e-05	0.0082	CrCbGaD
Alimemazine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	5.52e-05	0.00805	CrCbGaD
Alimemazine—Thioproperazine—ALB—type 2 diabetes mellitus	5.49e-05	0.00801	CrCbGaD
Alimemazine—Pipotiazine—ALB—type 2 diabetes mellitus	5.4e-05	0.00788	CrCbGaD
Alimemazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	5.33e-05	0.00778	CrCbGaD
Alimemazine—Imipramine—CYP2E1—type 2 diabetes mellitus	5.3e-05	0.00774	CrCbGaD
Alimemazine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	5.27e-05	0.00769	CrCbGaD
Alimemazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	5.07e-05	0.0074	CrCbGaD
Alimemazine—Imipramine—CYP1A2—type 2 diabetes mellitus	5.05e-05	0.00736	CrCbGaD
Alimemazine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	5.01e-05	0.00732	CrCbGaD
Alimemazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	4.9e-05	0.00714	CrCbGaD
Alimemazine—Trimipramine—CYP3A4—type 2 diabetes mellitus	4.5e-05	0.00657	CrCbGaD
Alimemazine—Doxepin—CYP3A4—type 2 diabetes mellitus	4.29e-05	0.00626	CrCbGaD
Alimemazine—Clomipramine—ALB—type 2 diabetes mellitus	4.27e-05	0.00623	CrCbGaD
Alimemazine—Methadone—CYP3A4—type 2 diabetes mellitus	4.27e-05	0.00623	CrCbGaD
Alimemazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	4.23e-05	0.00618	CrCbGaD
Alimemazine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	4.18e-05	0.0061	CrCbGaD
Alimemazine—Desipramine—CYP3A4—type 2 diabetes mellitus	3.94e-05	0.00575	CrCbGaD
Alimemazine—Promazine—CYP3A4—type 2 diabetes mellitus	3.82e-05	0.00557	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	3.64e-05	0.00195	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	3.61e-05	0.00193	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	3.59e-05	0.00192	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.57e-05	0.00191	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	3.55e-05	0.0019	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	3.55e-05	0.0019	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	3.49e-05	0.00186	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.46e-05	0.00185	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	3.45e-05	0.00184	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.41e-05	0.00182	CbGpPWpGaD
Alimemazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	3.36e-05	0.0049	CrCbGaD
Alimemazine—Imipramine—CYP3A4—type 2 diabetes mellitus	3.34e-05	0.00487	CrCbGaD
Alimemazine—HRH1—Signaling by GPCR—GIP—type 2 diabetes mellitus	3.32e-05	0.00178	CbGpPWpGaD
Alimemazine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	3.32e-05	0.00484	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—GCG—type 2 diabetes mellitus	3.29e-05	0.00176	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	3.21e-05	0.00172	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	3.12e-05	0.00167	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	3.11e-05	0.00166	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	3.05e-05	0.00163	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	3.01e-05	0.00161	CbGpPWpGaD
Alimemazine—Chlorpromazine—ALB—type 2 diabetes mellitus	2.93e-05	0.00427	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	2.9e-05	0.00155	CbGpPWpGaD
Alimemazine—Amitriptyline—ALB—type 2 diabetes mellitus	2.9e-05	0.00423	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	2.87e-05	0.00153	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.86e-05	0.00152	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	2.83e-05	0.00151	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	2.83e-05	0.00151	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.82e-05	0.00151	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.82e-05	0.0015	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	2.81e-05	0.0015	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	2.79e-05	0.00149	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.78e-05	0.00149	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	2.75e-05	0.00147	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	2.73e-05	0.00146	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	2.68e-05	0.00143	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	2.66e-05	0.00142	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	2.64e-05	0.00141	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	2.5e-05	0.00133	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	2.43e-05	0.0013	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	2.42e-05	0.00129	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	2.39e-05	0.00128	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	2.39e-05	0.00127	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	2.38e-05	0.00127	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	2.37e-05	0.00127	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	2.32e-05	0.00124	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	2.32e-05	0.00124	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	2.3e-05	0.00123	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.23e-05	0.00119	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.23e-05	0.00119	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	2.21e-05	0.00118	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	2.21e-05	0.00118	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.16e-05	0.00116	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	2.16e-05	0.00115	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	2.14e-05	0.00114	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.13e-05	0.00114	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.1e-05	0.00112	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.09e-05	0.00112	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.08e-05	0.00111	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.04e-05	0.00109	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.04e-05	0.00109	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.03e-05	0.00108	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.01e-05	0.00107	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2e-05	0.00107	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	1.96e-05	0.00105	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	1.95e-05	0.00104	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	1.89e-05	0.00101	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	1.87e-05	0.000997	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	1.86e-05	0.000994	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	1.86e-05	0.000992	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	1.85e-05	0.000989	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	1.84e-05	0.000985	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	1.83e-05	0.000976	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	1.82e-05	0.000973	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	1.82e-05	0.00097	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	1.78e-05	0.000952	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	1.73e-05	0.000926	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	1.69e-05	0.000901	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	1.67e-05	0.000892	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	1.66e-05	0.000886	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.65e-05	0.000881	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.61e-05	0.000861	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	1.6e-05	0.000855	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	1.58e-05	0.000843	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.5e-05	0.000802	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.49e-05	0.000795	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.48e-05	0.000788	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.48e-05	0.000788	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.45e-05	0.000776	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.44e-05	0.00077	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.44e-05	0.00077	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.44e-05	0.000768	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.44e-05	0.000768	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.43e-05	0.000766	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.43e-05	0.000766	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	1.43e-05	0.000764	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.43e-05	0.000762	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.41e-05	0.000755	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.37e-05	0.00073	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.37e-05	0.00073	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.36e-05	0.000729	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.34e-05	0.000717	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.31e-05	0.000701	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.3e-05	0.000697	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.3e-05	0.000692	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.28e-05	0.000684	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.27e-05	0.00068	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.27e-05	0.000676	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.25e-05	0.000666	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.24e-05	0.000664	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.24e-05	0.000663	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.24e-05	0.00066	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.22e-05	0.000651	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.2e-05	0.000643	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.2e-05	0.000643	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.19e-05	0.000636	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.18e-05	0.000632	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.16e-05	0.000621	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.16e-05	0.000621	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.16e-05	0.000621	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.16e-05	0.000621	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.16e-05	0.000621	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.15e-05	0.000615	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.15e-05	0.000614	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.15e-05	0.000614	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.13e-05	0.000605	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.13e-05	0.000601	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.12e-05	0.000597	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.11e-05	0.000595	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.11e-05	0.000594	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.09e-05	0.000584	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.09e-05	0.000582	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.09e-05	0.000582	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.08e-05	0.000575	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.06e-05	0.000568	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.06e-05	0.000568	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.05e-05	0.000559	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.04e-05	0.000553	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.01e-05	0.000541	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.01e-05	0.000539	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.96e-06	0.000532	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.96e-06	0.000532	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.89e-06	0.000528	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.89e-06	0.000528	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.89e-06	0.000528	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.8e-06	0.000523	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.77e-06	0.000522	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.48e-06	0.000506	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.48e-06	0.000506	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	9.33e-06	0.000498	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.16e-06	0.000489	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.15e-06	0.000489	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.12e-06	0.000487	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.12e-06	0.000487	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.96e-06	0.000479	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.81e-06	0.000471	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.81e-06	0.000471	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.81e-06	0.000471	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.67e-06	0.000463	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.59e-06	0.000459	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	8.47e-06	0.000452	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.47e-06	0.000452	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.43e-06	0.00045	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.4e-06	0.000448	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.31e-06	0.000444	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.28e-06	0.000442	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	8.19e-06	0.000437	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.16e-06	0.000436	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.06e-06	0.00043	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.82e-06	0.000418	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.76e-06	0.000414	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.65e-06	0.000409	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.49e-06	0.0004	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.49e-06	0.0004	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.49e-06	0.0004	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.49e-06	0.0004	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.34e-06	0.000392	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.2e-06	0.000385	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.18e-06	0.000384	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	7.04e-06	0.000376	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.71e-06	0.000359	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.7e-06	0.000358	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.69e-06	0.000357	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.68e-06	0.000357	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.58e-06	0.000351	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.55e-06	0.00035	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.55e-06	0.00035	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.48e-06	0.000346	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.23e-06	0.000333	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.18e-06	0.00033	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.11e-06	0.000326	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.11e-06	0.000326	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.99e-06	0.00032	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.95e-06	0.000318	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.95e-06	0.000318	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.95e-06	0.000318	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.92e-06	0.000316	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.85e-06	0.000312	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.81e-06	0.00031	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.74e-06	0.000307	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	5.6e-06	0.000299	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.51e-06	0.000294	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.42e-06	0.000289	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.41e-06	0.000289	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.39e-06	0.000288	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.34e-06	0.000285	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.34e-06	0.000285	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.34e-06	0.000285	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.24e-06	0.00028	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.19e-06	0.000277	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.14e-06	0.000275	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.08e-06	0.000271	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.91e-06	0.000262	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.91e-06	0.000262	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.88e-06	0.000261	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.83e-06	0.000258	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.83e-06	0.000258	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.63e-06	0.000247	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.63e-06	0.000247	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.62e-06	0.000247	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.21e-06	0.000225	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.17e-06	0.000223	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.14e-06	0.000221	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.99e-06	0.000213	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.99e-06	0.000213	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.97e-06	0.000212	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.94e-06	0.00021	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.92e-06	0.000209	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.9e-06	0.000208	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.82e-06	0.000204	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.8e-06	0.000203	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.7e-06	0.000198	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.63e-06	0.000194	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.63e-06	0.000194	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.56e-06	0.00019	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.54e-06	0.000189	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.54e-06	0.000189	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.45e-06	0.000184	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.41e-06	0.000182	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.27e-06	0.000175	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.25e-06	0.000173	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.21e-06	0.000171	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.18e-06	0.00017	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.11e-06	0.000166	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.06e-06	0.000163	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.04e-06	0.000163	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.01e-06	0.000161	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.65e-06	0.000142	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.6e-06	0.000139	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.45e-06	0.000131	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.38e-06	0.000127	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.28e-06	0.000122	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.28e-06	0.000122	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.26e-06	0.000121	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.09e-06	0.000111	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-06	5.6e-05	CbGpPWpGaD
